Use of rasH2 transgenic mice for carcinogenesis testing of medical implants

Experimental and Toxicologic Pathology

Volumn 61, Issue 5, 2009, Pages 433-441

  Palazzi, Xavier ^a   Kergozien Framery, Sylvie ^a  

^a Biomatech Namsa Labs   (France)

Author keywords

Animal model; Carcinogenicity; Medical device; Mouse; Pathology; rasH2; Transgenic

Indexed keywords

METHYLNITROSOUREA; POLYETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DISEASE MODEL; FATALITY; FEMALE; IMPLANT; MALE; MOUSE; NONHUMAN; PAPILLOMA; SURVIVAL RATE; THYMUS LYMPHOMA; TOXICITY TESTING; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENES, RAS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MUTAGENICITY TESTS; PROSTHESES AND IMPLANTS; RAS PROTEINS;

ANIMALIA; MUS; MUS MUSCULUS; RODENTIA;

EID: 68549119145     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.10.008     Document Type: Article

References (9)

1. Blanchard K.T., et al. Transponder-induced sarcoma in the heterozygous p53+/- mouse. Toxicol Pathol 27 (1999) 519-527
2. Dulbecco R., and Armstrong B. Stochastic development of invasive potential in rat mammary tumors induced by N-methyl-N-nitrosourea. Proc Natl Acad Sci USA 85 22 (1988) 8659-8663
3. Gulezian D., et al. Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment. Toxicol Pathol 28 (2000) 482-499
4. IARC Monographs on the evaluation of carcinogenic risk to humans, 1999. Surgical implants and other foreign bodies, vol. 74. Lyon, France.
5. Kirkpatrick C.J., et al. Biomaterial-induced sarcoma: a novel model to study preneoplastic change. Am J Pathol 156 (2000) 1455-1467
6. Morton D., et al. The Tg rasH2 Mouse in cancer hazard identification. Toxicol Pathol 30-1 (2002) 139-146
7. Takaoka M., et al. Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice. Toxicol Pathol 31 (2003) 191-199
8. Yamamoto S., et al. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-trangenic mice. Carcinogenesis 11 (1996) 2455-2461
9. Yamamoto S., et al. Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Lab Anim Sci 47 (1997) 121-126